178 related articles for article (PubMed ID: 23818753)
1. Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants.
Brynskov T; Laugesen CS; Halborg J; Kemp H; Sørensen TL
Clin Ophthalmol; 2013; 7():1171-4. PubMed ID: 23818753
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal injection of dexamethasone implant and ranibizumab in cystoid macular edema in the course of irvine-gass syndrome.
Fenicia V; Balestrieri M; Perdicchi A; MauriziEnrici M; DelleFave M; Recupero SM
Case Rep Ophthalmol; 2014 May; 5(2):243-8. PubMed ID: 25232337
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of postoperative cystoid macular edema (Irvine-Gass syndrome) with dexamethasone 0.7 mg intravitreal implant].
Landré C; Zourdani A; Gastaud P; Baillif S
J Fr Ophtalmol; 2016 Jan; 39(1):5-11. PubMed ID: 26520410
[TBL] [Abstract][Full Text] [Related]
4. Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine-Gass Syndrome.
Marques JH; Abreu AC; Silva N; Meireles A; Pessoa B; Melo Beirão J
Int Med Case Rep J; 2021; 14():127-132. PubMed ID: 33664598
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.
Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U;
Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922
[TBL] [Abstract][Full Text] [Related]
6. Short-term safety and efficacy of intravitreal 0.7-mg dexamethasone implants for pseudophakic cystoid macular edema.
Al Zamil WM
Saudi J Ophthalmol; 2015; 29(2):130-4. PubMed ID: 25892932
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral buckling.
Bonfiglio V; Fallico MR; Russo A; De Grande V; Longo A; Uva MG; Reibaldi M; Avitabile T
Eur J Ophthalmol; 2015 Jul; 25(5):e98-e100. PubMed ID: 25790811
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Intravitreal Injection of Filtered Modified Low-Dose Triamcinolone Acetonide and Ranibizumab on Pseudophakic Cystoid Macular Edema.
Tariq F; Wang Y; Ma B; He Y; Zhang S; Bai L
Front Med (Lausanne); 2022; 9():777549. PubMed ID: 35252233
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature.
Sacchi M; Villani E; Gilardoni F; Nucci P
Clin Ophthalmol; 2014; 8():1253-7. PubMed ID: 25061272
[TBL] [Abstract][Full Text] [Related]
10. Cystoid Macular Edema after Complicated Cataract Surgery Resolved by an Intravitreal Dexamethasone 0.7-mg Implant.
Meyer LM; Schönfeld CL
Case Rep Ophthalmol; 2011 Sep; 2(3):319-22. PubMed ID: 22125533
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema.
Altintas AGK; Ilhan C
Korean J Ophthalmol; 2019 Jun; 33(3):259-266. PubMed ID: 31179657
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases.
Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
Therapie; 2016 Oct; 71(5):457-465. PubMed ID: 27203164
[TBL] [Abstract][Full Text] [Related]
13. RANIBIZUMAB FOR DIABETIC MACULAR EDEMA REFRACTORY TO MULTIPLE PRIOR TREATMENTS.
Ciulla TA; Hussain RM; Ciulla LM; Sink B; Harris A
Retina; 2016 Jul; 36(7):1292-7. PubMed ID: 26583309
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetes.
Khurana RN; Palmer JD; Porco TC; Wieland MR
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):56-61. PubMed ID: 25559510
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone intravitreal implants for diabetic macular edema refractory to ranibizumab monotherapy or combination therapy.
Gutiérrez-Benítez L; Millan E; Arias L; Garcia P; Cobos E; Caminal M
Arch Soc Esp Oftalmol; 2015 Oct; 90(10):475-80. PubMed ID: 26008920
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal ranibizumab for the treatment of cystoid macular edema in Irvine-Gass syndrome.
Demirel S; Batioğlu F; Özmert E
J Ocul Pharmacol Ther; 2012 Dec; 28(6):636-9. PubMed ID: 22731243
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
18. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
[TBL] [Abstract][Full Text] [Related]
20. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
Bernard Y; Bonnin N; Farguette F; Chiambaretta F
J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
